| |
| |
|
| Insider
Information: |
Ringo William R |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
301,607 |
|
|
Indirect Shares
|
2,341 |
|
|
| Direct
Value |
$7,500,880 |
|
|
|
Indirect Value
|
$69,294 |
|
|
| Total
Shares |
303,948 |
|
|
| Total
Value |
$7,570,173 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 64.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Encysive Pharmaceuticals Inc |
ENCY |
Director |
2004-07-16 |
4,145 |
2003-07-09 |
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Former Director |
2008-07-23 |
0 |
2003-11-05 |
0 |
Premium* |
|
|
Allos Therapeutics Inc |
ALTH |
Director |
2007-01-05 |
3,000 |
|
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Senior Vice President |
2010-02-25 |
252,798 |
2010-02-25 |
2,341 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Director |
2017-09-20 |
800 |
2010-04-16 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2011-03-31 |
0 |
Premium* |
|
|
Assembly Biosciences Inc |
ASMB |
Director |
2020-02-28 |
17,465 |
2017-05-12 |
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2021-04-05 |
0 |
2016-08-01 |
0 |
Premium* |
|
|
Sensei Biotherapeutics, Inc. |
SNSE |
Director |
2023-07-10 |
23,399 |
2022-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-02-01 |
4 |
OE |
$11.65 |
$5,825 |
D/D |
500 |
500 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-03-01 |
4 |
OE |
$11.65 |
$5,825 |
D/D |
500 |
500 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-10-02 |
4 |
OE |
$11.65 |
$6,990 |
D/D |
600 |
600 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-11-01 |
4 |
OE |
$11.65 |
$6,990 |
D/D |
600 |
600 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2013-01-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2014-02-14 |
4 |
S |
$18.06 |
$451,575 |
D/D |
(25,000) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-01-05 |
4 |
S |
$15.20 |
$33,430 |
D/D |
(2,200) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-02-03 |
4 |
AS |
$12.70 |
$27,940 |
D/D |
(2,200) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-03-03 |
4 |
AS |
$17.21 |
$37,862 |
D/D |
(2,200) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-04-06 |
4 |
AS |
$14.95 |
$32,881 |
D/D |
(2,200) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-05-04 |
4 |
AS |
$12.98 |
$38,927 |
D/D |
(3,000) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-06-03 |
4 |
AS |
$12.44 |
$27,364 |
D/D |
(2,200) |
800 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2017-09-20 |
4 |
S |
$14.37 |
$445,597 |
D/D |
(31,000) |
800 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-09-29 |
4 |
OE |
$11.65 |
$13,980 |
D/D |
1,200 |
1,200 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2017-09-28 |
4 |
OE |
$11.65 |
$23,300 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$967,125 |
D/D |
(7,737) |
2,100 |
0 |
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
Director |
– • – |
2003-07-09 |
4 |
A |
$4.71 |
$1,625 |
D/D |
345 |
2,949 |
|
- |
|
| ALTH |
Allos Therapeutics Inc |
Director |
– • – |
2007-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-01-05 |
4 |
OE |
$6.41 |
$14,102 |
D/D |
2,200 |
3,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-02-03 |
4 |
OE |
$6.41 |
$14,102 |
D/D |
2,200 |
3,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-03-03 |
4 |
OE |
$6.41 |
$14,102 |
D/D |
2,200 |
3,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-04-06 |
4 |
OE |
$6.41 |
$14,102 |
D/D |
2,200 |
3,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2015-06-03 |
4 |
OE |
$6.05 |
$13,310 |
D/D |
2,200 |
3,000 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2006-02-23 |
4 |
S |
$18.94 |
$59,093 |
D/D |
(3,120) |
3,130 |
|
- |
|
| ENCY |
Encysive Pharmaceuticals ... |
Director |
– • – |
2003-10-13 |
4 |
A |
$5.94 |
$1,746 |
D/D |
294 |
3,243 |
|
- |
|
100 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
